Literature DB >> 3475213

Prevalence of HBV, HDV and HIV infections among intravenous drug addicts in Greece.

A Roumeliotou-Karayannis, N Tassopoulos, E Karpodini, E Trichopoulou, M Kotsianopoulou, G Papaevangelou.   

Abstract

The prevalence of HBV, HDV and HIV infection was studied in 288 imprisoned intravenous drug addicts (IVDA) and 329 controls. Commercially available radioimmunoassays for the detection of HBV and HDV serologic markers and enzyme-immunoassays for IgM anti-HBc and anti-HIV were used. Anti-HIV positive results were confirmed by Western Blot. The prevalence of HBV serologic markers among IVDA (77.1%) was found considerably higher than among controls (22.5%). An increased prevalence of HBsAg carriers (6.9%) and anti-HBc alone positives (9.7%) was also found. IVDA carriers were more frequently HBeAg positive (25.0%) and HDV serologic markers were detected in 35.0% (7/20) of them. Anti-HIV were detected in 6 (2.1%) IVDA but in none control. These data show the widespread HBV and HDV infections among Greek IVDA and suggest the need for continuation of the initiated hepatitis B vaccination program. Anti-HIV prevalence is yet low. However there is urgent need for an extensive campaign to limit the further spread of the HIV among this high risk group.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3475213     DOI: 10.1007/BF00239750

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  11 in total

1.  Chronic hepatic dysfunction in heroin addicts. Possible relation to carrier state of viral hepatitis.

Authors:  H P POTTER; N N COHEN; R F NORRIS
Journal:  JAMA       Date:  1960-12-17       Impact factor: 56.272

2.  Update: acquired immunodeficiency syndrome--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-01-17       Impact factor: 17.586

3.  Viral hepatitis associated with illicit parenteral use of drugs.

Authors:  W E Dismukes; A W Karchmer; R F Johnson; W J Dougherty
Journal:  JAMA       Date:  1968-10-28       Impact factor: 56.272

4.  Rapid spread of HTLV-III infection among drug addicts in Italy.

Authors:  G Angarano; G Pastore; L Monno; T Santantonio; N Luchena; O Schiraldi
Journal:  Lancet       Date:  1985-12-07       Impact factor: 79.321

5.  Hepatitis B surface antigen and antibody. A prospective study in asymptomatic drug abusers.

Authors:  B Stimmel; S Vernace; F Schaffner
Journal:  JAMA       Date:  1975-12-15       Impact factor: 56.272

6.  Diagnostic value of anti-HBc IgM in high HBV prevalence areas.

Authors:  G Papaevangelou; A Roumeliotou-Karayannis; N Tassopoulos; P Stathopoulou
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

7.  Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy.

Authors:  A Smedile; C Lavarini; P Farci; S Aricò; G Marinucci; P Dentico; G Giuliani; A Cargnel; C Del Vecchio Blanco; M Rizzetto
Journal:  Am J Epidemiol       Date:  1983-02       Impact factor: 4.897

8.  Viral hepatitis among parenteral drug addicts attending a Danish addiction clinic.

Authors:  F Scheutz; P Skinhøj; I Mark
Journal:  Scand J Infect Dis       Date:  1983

9.  Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections.

Authors:  A G Shattock; F M Irwin; B M Morgan; I B Hillary; M G Kelly; J F Fielding; D A Kelly; D G Weir
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-11

10.  Epidemiological studies on the prevalence of hepatitis Delta virus infections in the Federal Republic of Germany.

Authors:  M Roggendorf; K Gmelin; G Zoulek; P Wolf; U Schlipköter; W Jilg; L Theilmann; F Deinhardt
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

View more
  4 in total

1.  HIV infection in Greek intravenous drug users.

Authors:  G Papaevangelou; A Roumeliotou; G Stergioy; A Nestoridou; E Trichopoulou; G Kallinikos; G Rizos; E Kornarou
Journal:  Eur J Epidemiol       Date:  1991-01       Impact factor: 8.082

2.  Prevalence of hepatitis B and C markers among refugees in Athens.

Authors:  Anastasios Roussos; Constantin Goritsas; Thomas Pappas; Maria Spanaki; Panagiota Papadaki; Angeliki Ferti
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

3.  Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees.

Authors:  V Sypsa; E Hadjipaschali; A Hatzakis
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

4.  New data concerning the epidemiology of Hepatitis B virus infection in Greece.

Authors:  Konstantinos D Pantazis; Ioannis S Elefsiniotis; Hero Brokalaki
Journal:  Gastroenterol Res Pract       Date:  2008       Impact factor: 2.260

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.